SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Ooley who wrote (23)2/12/1997 3:21:00 PM
From: Cindy Powell   of 196
 
David and All,

During my last conversation with MLSC, I attemped to get an idea of the time factor that may be involved in the company's moving forward with their business objectives, and the conversation was basically diverted to the funding issue.

MLSC is currently negotiating with several potential partners and they are being very selective and protective as to how much of the company they are willing to part with. They realize they are going to have to make some concessions and are looking into the possibility of forming some kind of a limited partnership with a larger company.

Below are names and numbers of some of the research labs where some of the research has been conducted, for those of you who are interested in doing some independant verification.

UCLA Clinical Microbiology Lab
Dr. Bruckner
(You will need to look the phone number up.)

Indiana University School of Dentistry
Dr. Chris H. Miller
(317) 274-4561

Albany Research Institute of N.Y.
Dr. Aldona Baltch
(518) 462-3311 ext. 3080

I will be posting more information over the coming week or so,
so stay tuned...

Cindy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext